Stimulant formulation and motivation for nonmedical use of prescription attention-deficit/hyperactivity disorder medications in a college-aged population.
There is relatively little research examining motives for nonmedical use (NMU) of attention-deficit/hyperactivity disorder (ADHD) medications and predictors of motivation. We present results of a secondary analysis of an Internet-based epidemiological survey to explore the relationship between stimulant formulation and motivation for NMU of ADHD stimulant medications in a college-aged population. Demographic predictors of motivation to engage in NMU were also explored to investigate the potential correlates of recreational versus performance-enhancement motivations. Respondents scoring higher on the Adult ADHD Self-Report Scale were significantly more likely to engage in NMU of ADHD stimulant medications. Those using extended release (ER) stimulant formulations were less likely to endorse "staying awake" as a reason for NMU compared to those using immediate release (IR) stimulant formulations.
Eli Lilly and Company and/or one of its subsidiaries, Lilly Research Laboratories, Indianapolis, Indiana 46285, USA. upadhyayahp@lilly.com
Himanshu P
HP
Upadhyaya
Larry A
LA
Kroutil
Deborah
D
Deas
Todd M
TM
Durell
David L
DL
Van Brunt
Scott P
SP
Novak
D000293:Adolescent; D000294:Adolescent Behavior / Q000187:drug effects / Q000523:psychology*; D000328:Adult; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000009:adverse effects*; D002626:Chemistry, Pharmaceutical; D003692:Delayed-Action Preparations / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D009042:Motivation; D055553:Prescription Drugs / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D012651:Self Medication / Q000523:psychology*; D014495:Universities
D000697:Central Nervous System Stimulants; D003692:Delayed-Action Preparations; D055553:Prescription Drugs